title: Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with RA?
authors.forename: S L
authors.initials: SL
authors.lastname: Hider
authors.forename: C
authors.initials: C
authors.lastname: Morgan
authors.forename: E
authors.initials: E
authors.lastname: Bell
authors.forename: I N
authors.initials: IN
authors.lastname: Bruce
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000097:blood; D000368:Aged; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000235:genetics*; D004351:Drug Resistance / Q000235:genetics; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use*; D008875:Middle Aged; D018709:Statistics, Nonparametric
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D018501:Antirheumatic Agents; D008727:Methotrexate